HomeInsightsMarket Capitalization

Market Capitalization of Ind-swift Laboratories Ltd

Market Capitalization of Ind-swift Laboratories Ltd

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

2.9 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Ind-Swift Laboratories Ltd

NSE: INDSWFTLAB

Market Cap

₹ 601.8 crore

Last updated on: Nov 22, 2024

Key Highlights

  • The Market Cap of Ind-Swift Laboratories Ltd is ₹ 601.8 crore as of 22 Nov 24 .
  • The Market Cap of Ind-Swift Laboratories Ltd changed from ₹ 186.71 crore on March 2019 to ₹ 580.82 crore on March 2024 . This represents a CAGR of 20.82% over 6 years.
  • The Latest Trading Price of Ind-Swift Laboratories Ltd is ₹ 101.85 as of 22 Nov 15:30 .

Historical Market Cap of Ind-Swift Laboratories Ltd

No data available

* All values are in crore

Company Fundamentals for Ind-Swift Laboratories Ltd

No data available

Image

Ind-Swift Laboratories Ltd

NSE: INDSWFTLAB

Share Price

₹ 101.85

-2.05 (-1.97%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Ind-Swift Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Ind-Swift Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024101.85
21 Nov 2024103.9
19 Nov 2024106
18 Nov 2024104.05
14 Nov 2024106
13 Nov 2024106.7
12 Nov 2024108.5
11 Nov 2024110.55
08 Nov 2024112.5
07 Nov 2024114

SWOT Analysis Of Ind-Swift Laboratories Ltd

Strength

5

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Ind-Swift Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Ind-Swift Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Ind-Swift Laboratories Ltd

No data available

No data available

Historical P/E Ratio of Ind-Swift Laboratories Ltd

No data available

* All values are in %

Historical Revenue of Ind-Swift Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Ind-Swift Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Ind-Swift Laboratories Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

About Ind-Swift Laboratories Ltd

  • Ind-Swift Laboratories Ltd is a part of the Ind-swift Group and is based at Chandigarh, India.
  • The company manufactures and sells active pharmaceutical ingredients (API).
  • Their product pipeline consists of 25 products, which includes drugs, which include Clarithromycin (Macrolide antibiotic), Atorvastatin (anticholestrol), Fexofenadine (antihistamine), Clopidogrel (anticholestrol), Nitazoxanide (antidiarrheal), Pioglitazone (antidiabetic), Letrozole and Anastrozole (anticancer), Venlafaxine (antidepressants) and Quetipine and Aripirazole (antipsychotic).
  • The company has one subsidiary namely, Ind-Swift Laboratories Inc in USA. Ind-Swift Laboratories Ltd was incorporated on January 4, 1995 as a joint venture between Ind-Swift Ltd and Punjab State Industrial Development Corporation.
  • Later, Ind-Swift purchased Punjab State Industrial Development Corporation equity to emerge as a single largest shareholder in the company.

Ind-Swift Laboratories Ltd News Hub

News

Ind-Swift Laboratories to declare Quarterly Result

Ind-Swift Laboratories will hold a meeting of the Board of Directors of the Company on 11 ...

Read more

08 Nov 202411:47

News

Ind-Swift Laboratories to hold AGM

Ind-Swift Laboratories announced that the Annual General Meeting (AGM) of the company will...

Read more

03 Sep 202411:38

News

Ind-Swift Laboratories to discuss results

Ind-Swift Laboratories will hold a meeting of the Board of Directors of the Company on 12 ...

Read more

03 Aug 202410:44

News

Ind-Swift Laboratories schedules EGM

Ind-Swift Laboratories announced that an Extra Ordinary General Meeting (EGM) of the Compa...

Read more

29 Jun 202417:29

News

Ind-Swift Laboratories schedules board meeting

Ind-Swift Laboratories will hold a meeting of the Board of Directors of the Company on 27 ...

Read more

25 Jun 202410:22

News

Ind-Swift Labs board to mull fund raising

The company’s board will meet to consider and approve the proposal for raising of funds by...

Read more

25 Jun 202408:19

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Ind-Swift Laboratories Ltd Market Cap

What is the market cap of Ind-Swift Laboratories Ltd?

As of November 23, 2024, Ind-Swift Laboratories Ltd has a market capitalization of ₹601.8, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Ind-Swift Laboratories Ltd's market capitalization?

Ind-Swift Laboratories Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Ind-Swift Laboratories Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Ind-Swift Laboratories Ltd's market capitalization change?

Ind-Swift Laboratories Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*